Bb5a31f81ClaimTahoe Therapeutics published open-source perturbation datasets measuring molecular interactions with biological cells to facilitate virtual cell simulationAgreeDisagree
Bb5a31f81ClaimProfluent entered into an agreement valued at over $2 billion with Eli Lilly to bring AI-generated proteins into clinical developmentAgreeDisagree
Bb5a31f81ClaimRichard Socher's concept of a Eureka Machine envisions AI systems that autonomously generate ideas, run experiments, and validate discoveries across scientific disciplinesAgreeDisagree
Bb5a31f81ClaimParallel Bio develops human organoids from pluripotent stem cells derived from human blood or skin cellsAgreeDisagree
Bb5a31f81ClaimThe WHOOP platform integrates user-uploaded blood testing results and medical records alongside continuous physiological sensor dataAgreeDisagree
Bb5a31f81ClaimApproximately 80 percent of WHOOP's member base interacts with the in-app WHOOP AI coachAgreeDisagree
Bb5a31f81ClaimStanford Health Care selected OpenAI's o3-mini model for the Surgical Co-management Navigator after benchmarking five candidate models against consensus chart reviewsAgreeDisagree
Bb5a31f81ClaimStanford Health Care developed the Surgical Co-management Navigator to screen next-day elective surgeries for surgical co-management eligibilityAgreeDisagree
Bb5a31f81ClaimStanford Health Care's Surgical Co-management Navigator retrieves pre-operative anesthesia notes and medication records from electronic health recordsAgreeDisagree
Bb5a31f81ClaimPhysicians declined approximately 40 percent of patients flagged by Stanford Health Care's Surgical Co-management Navigator due to low surgical complexityAgreeDisagree
Bb5a31f81ClaimPhysicians using Stanford Health Care's Surgical Co-management Navigator agreed with the system's negative screening determinations 97 percent of the timeAgreeDisagree
Bb5a31f81ClaimPrior to the deployment of Stanford Health Care's Surgical Co-management Navigator, routine human triage missed 50 percent of eligible surgical co-management patientsAgreeDisagree
Bb5a31f81ClaimAnthropic established partnerships with six organizations alongside launching proprietary drug discovery initiativesAgreeDisagree
Bb5a31f81ClaimMithril Medicine advanced an antibody treatment candidate for muscular dystrophy from initial concept to proof of principle in mice within 18 monthsAgreeDisagree
Bb5a31f81ClaimAnthropic entered into a partnership with Bristol Myers Squibb to apply artificial intelligence to early-stage clinical trial planningAgreeDisagree
Bb5a31f81ClaimAnthropic published an outline detailing its strategy to integrate artificial intelligence across every stage of the drug discovery processAgreeDisagree
Bb5a31f81ClaimMithril Medicine founder Cody Tranbarger utilized Anthropic's Claude model to coordinate experiments, logistics, and contracts across 11 external laboratoriesAgreeDisagree
Bb5a31f81ClaimMustafa Suleyman's early healthcare AI initiatives with the United Kingdom National Health Service at DeepMind stalled due to regulatory bureaucracy and data privacy concernsAgreeDisagree
Bb5a31f81ClaimA University of Chicago analysis of 41 million scientific papers found that researchers using AI publish more papers and receive more citationsAgreeDisagree
Bb5a31f81ClaimA University of Chicago analysis of 41 million scientific papers found that AI use narrowed the range of scientific topics studied by almost 5%AgreeDisagree